Policy

Latest News

FDA | Image credit: wladimir1804 - stock.adobe.com
FDA Draft Guidance Removes Switching Study Requirements for Biosimilar Interchangeability

June 20th 2024

The FDA has issued an update to its guidance on requiring switching study data for biosimilars to be granted interchangeability, citing new science that shows these studies aren’t needed to establish biosimilar safety.

economic barriers to biosimilars | Image credit: gopixa - stock.adobe.com
Overcoming Economic, Noneconomic Barriers to Biosimilar Adoption in Oncology

June 20th 2024

Health Equity Chart | Image Credit: leowolfert - stock.adobe.com
Part 2: Unlocking the Potential of Biosimilars to Improve Health Equity

June 19th 2024

canada biosimilars | Image credit: Rawf8 - stock.adobe.com
British Columbia’s Biosimilar Switching Program Saves $732 Million in 5 Years

June 18th 2024

Biosimilars Check-In banner
Biosimilars Check-In: Application Acceptances, European Approvals, New Partnerships

June 6th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.